Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer pulls sickle cell treatment Oxbryta
Pfizer withdraws sickle-cell disease treatment
U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks of a painful complication and deaths.
Pfizer pulls sickle cell drug oxbryta, raising safety concerns
Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.
Sickle cell community scrambles to find safe plan after a drug is pulled from the market
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left scrambling to figure out what to do.
Pfizer’s Strategy Looks Shakier After Sickle-Cell Disappointment
The company said it was withdrawing Oxbryta, a daily pill for patients with the disease, a serious, lifelong condition.
Pfizer Sickle Cell Drug Suspended by Europe in New Setback
All data considered, the benefit of the therapy, Oxbryta, “no longer outweighs the risk,” Pfizer said in a statement Wednesday. The company, which also announced discontinuing clinical trials as it investigates the findings,
Pfizer’s Oxbryta Withdrawal Leaves Sickle Cell Community Scrambling, Investors Reeling
Pfizer’s sudden market withdrawal of sickle cell therapy Oxbryta, which some analysts predicted would reach $750 million in sales by the end of the decade, has left patients and healthcare providers with few options,
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.
Pfizer to Withdraw Sickle-Cell Drug Oxbryta From Worldwide Markets
The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the approved sickle cell patient population.
Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety Concerns
Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. Pfizer ( PFE) shares declined Thursday after the drug maker recalled all lots of its sickle cell disease medicine worldwide because of concerns it could lead to severe pain and possibly death in patients.
Pfizer yanks sickle-cell treatment worldwide after possible link to deaths
Pfizer Inc. said late Wednesday it was withdrawing a sickle-cell drug from markets worldwide and discontinuing clinical trials of the treatment after it investigates data suggesting a potential link to sickle-cell complications and “fatal events.”
Pfizer pulls sickle cell treatment Oxbryta off global markets
The company said benefits no longer outweighed the risks, with data suggesting the drug might increase the risk of pain crises and "fatal events."
Medscape
5h
Pfizer's Withdrawal of SCD Drug Raises Questions
Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...
4h
Pfizer starts voluntary withdraw of OXBRYTA, benefit does not outweigh risks
Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene death toll rises
‘Ring of fire’ eclipse in Oct
Illegal cloning sentencing
Harris' Las Vegas rally
NYC tunnel shutdown
Grammy-winning singer dies
Trump's Erie rally
Blocks songs from artists
Crew-9 astronauts at ISS
Oil prices climb
Three PFLP leaders killed
Firefighters injured in crash
Actor John Ashton dies
Defensive Player of the Year
Line Fire prompts evacuation
$567M Taiwan defense aid
US wins Presidents Cup
Newsom vetoes AI safety bill
37 militants killed in Syria
‘Wild Robot' tops box office
'Days of Our Lives' star dies
NC small plane crash
Hospitalized for burns
Temporary outage fixed
Ga. chemical plant fire
Condemns Israeli strikes
Ukrainian drones shot down
'SNL' launches 50th season
Steward CEO to step down
Faces fine to end Brazil ban
Chief adviser subpoenaed
Feedback